Corradina Caraco

Naples, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

PET/MRI of hypoxia and vascular function in ER-positive breast cancer: correlations with immunohistochemistry.

PET/MRI of hypoxia and vascular function in ER-positive breast cancer: correlations with immunohistochemistry.

Journal: European radiology
Published: December 16, 2022

Imaging and treatment of brain tumors through molecular targeting: Recent clinical advances.

Imaging and treatment of brain tumors through molecular targeting: Recent clinical advances.

Journal: European journal of radiology
Published: March 15, 2021

Opportunities in cancer imaging: risk-adapted breast imaging in screening.

Opportunities in cancer imaging: risk-adapted breast imaging in screening.

Journal: Clinical radiology
Published: October 30, 2020

The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy.

The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy.

Journal: Nuclear medicine and biology
Published: May 25, 2020

Hypoxia and perfusion in breast cancer: simultaneous assessment using PET/MR imaging.

Hypoxia and perfusion in breast cancer: simultaneous assessment using PET/MR imaging.

Journal: European radiology
Published: February 26, 2020

18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer.

18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 27, 2018

Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.

Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.

Journal: Oncotarget
Published: August 26, 2016

Sequential PET/CT with [18F]-FDG Predicts Pathological Tumor Response to Preoperative Short Course Radiotherapy with Delayed Surgery in Patients with Locally Advanced Rectal Cancer Using Logistic Regression Analysis.

Sequential PET/CT with [18F]-FDG Predicts Pathological Tumor Response to Preoperative Short Course Radiotherapy with Delayed Surgery in Patients with Locally Advanced Rectal Cancer Using Logistic Regression Analysis.

Journal: PloS one
Published: July 05, 2016

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).

Journal: BMC cancer
Published: November 07, 2015

Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: Results of the BRANCH trial.

Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: Results of the BRANCH trial.

Journal: Oncotarget
Published: May 17, 2015

Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).

Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).

Journal: Endocrine
Published: April 27, 2015

Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.

Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 19, 2013
Showing 1-12 of 18

Last Updated: 09/26/2026